What Glucagon-Like Peptide-1 (GLP-1) Is

Glucagon-like peptide-1 (GLP-1) is a hormone your body makes naturally in the small intestine when you eat. It tells your pancreas to release insulin, slows how fast your stomach empties food, and sends signals to your brain that you feel full. Medications that mimic this hormone—called GLP-1 receptor agonists—are designed to do the same thing artificially.

The most well-known GLP-1 medications are semaglutide (brand names Ozempic, Wegovy, and Rybelsus) and tirzepatide (Zepbound, Mounjaro). These are injected weekly or taken by mouth, depending on the type. They were originally developed to treat type 2 diabetes, but research showed they also reduce body weight and may lower heart disease risk in some people.

GLP-1 medications are not the same as insulin. They work by mimicking a natural process your body already uses, rather than replacing a missing hormone. This distinction matters because it affects how they work, who can use them, and what side effects might occur.

Key Takeaways

  • GLP-1 medications work by slowing stomach emptying, increasing feelings of fullness, and helping your pancreas release insulin at the right times.
  • These medications were first approved for type 2 diabetes but are now also used for weight management in people without diabetes.
  • Common side effects include nausea, vomiting, and constipation, especially when starting or increasing the dose.
  • GLP-1 medications require ongoing injections or pills and cost hundreds of dollars per month without insurance coverage.
  • People with a personal or family history of thyroid cancer or multiple endocrine neoplasia should not use GLP-1 medications.

How GLP-1 Medications Affect Your Body

When you take a GLP-1 medication, it binds to receptors in your pancreas, stomach, and brain. In the pancreas, it triggers insulin release when blood sugar rises—the same response your natural GLP-1 would trigger. This helps keep blood sugar stable, which is why these drugs work for diabetes.

In your stomach, GLP-1 slows the rate at which food moves into your small intestine. This means you feel full longer after eating and are less likely to feel hungry between meals. In your brain, it acts on appetite centers, reducing cravings and the desire to eat. These combined effects typically lead to eating less food overall.

The weight loss people experience on GLP-1 medications comes primarily from eating fewer calories, not from the drug "burning" calories or speeding up metabolism. Studies show people on these medications lose an average of 10 to 22 percent of their body weight over 68 weeks, though results vary widely based on genetics, diet, and exercise.

Common Side Effects and What to Expect

Nausea is the most frequent side effect, especially in the first few weeks or when the dose increases. Vomiting, constipation, and diarrhea also occur in a significant number of people. These effects usually improve over time as your body adjusts, but they can be severe enough that some people stop taking the medication.

Less common but more serious side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, and changes in vision. Some people report muscle loss along with fat loss, which can be a concern if you are not exercising during treatment. Dehydration is also possible because nausea and vomiting can make it hard to drink enough water.

If you stop taking a GLP-1 medication, the effects wear off within days to weeks. Most people regain weight they lost, sometimes returning to their starting weight or higher. This is why these medications are considered long-term treatments rather than a one-time fix.

Who Uses GLP-1 Medications and Why

People with type 2 diabetes use GLP-1 medications to lower blood sugar and reduce the risk of heart attack and stroke. People without diabetes but with obesity may use them for weight loss, especially if they have weight-related health problems like high blood pressure or joint pain.

Some people use GLP-1 medications off-label—meaning for purposes not officially approved by the FDA—such as weight loss in people without diabetes or to manage binge eating. Insurance coverage varies: most plans cover GLP-1 for diabetes, but coverage for weight loss alone is less common and often requires meeting specific criteria like a BMI above 30 or the presence of weight-related conditions.

Athletes and people focused on performance sometimes use GLP-1 medications to reduce body fat while training, though this use is not well-studied in healthy people and carries unknown risks. The long-term effects of these medications in people without diabetes remain an active area of research.

Cost and How to Access GLP-1 Medications

Without insurance, a month's supply of a GLP-1 medication costs between $900 and $1,500, depending on the specific drug and dose. With insurance, your out-of-pocket cost depends on your plan—some cover the full cost, while others require a copay of $50 to $250 per month or more. Many insurance plans require prior authorization, meaning your doctor must submit paperwork proving medical need before the plan will pay.

Some manufacturers offer patient information programs that reduce or eliminate cost for people who meet income requirements. Compounded versions of semaglutide—made by pharmacies rather than pharmaceutical companies—cost less (often $200 to $400 per month) but are not FDA-approved and may vary in purity and potency.

To start a GLP-1 medication, you need a prescription from a doctor or nurse practitioner. Telehealth services now offer these prescriptions, though quality and oversight vary. Your prescriber should check your medical history, take your blood pressure, and possibly order blood work before starting treatment.

Medical Conditions That Prevent GLP-1 Use

You should not take a GLP-1 medication if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). Animal studies showed these drugs can cause thyroid tumors, and while human studies have not confirmed this risk, the FDA requires a warning label.

People with severe kidney disease, severe gastrointestinal problems, or a history of pancreatitis should use these medications only under close medical supervision. Pregnancy is another contraindication—GLP-1 medications should be stopped at least two months before trying to become pregnant, as the effects on fetal development are not fully understood.

If you have diabetic retinopathy (eye damage from diabetes), rapid blood sugar changes from GLP-1 medications can temporarily worsen vision. This does not mean you cannot use the medication, but it means your eye doctor should monitor you closely during treatment.

What Happens After You Stop Taking GLP-1

Weight regain is the most common outcome after stopping a GLP-1 medication. Studies show people typically regain 50 to 70 percent of the weight they lost within a year of stopping, though some regain all of it. This happens because appetite hormones return to baseline and eating patterns often revert to what they were before treatment.

For people with diabetes, blood sugar control also returns to pre-treatment levels. This does not mean the medication "failed"—it means these drugs work only while you are taking them. Some people view this as a reason to stay on them long-term; others prefer to use them temporarily while building new eating and exercise habits.

Stopping suddenly is generally safe, though some people experience rebound hunger or nausea. Tapering the dose over a few weeks may reduce these effects, though research on the best way to stop is limited.

Frequently Asked Questions

Do GLP-1 medications work without diet and exercise changes?

Yes, they reduce appetite and slow stomach emptying regardless of diet or exercise. However, combining the medication with healthier eating and physical activity produces better results and may help you keep weight off after stopping the medication. The medication is a tool, not a replacement for lifestyle change.

Can I use GLP-1 if I have type 1 diabetes?

GLP-1 medications are not approved for type 1 diabetes and are not recommended. Type 1 is an autoimmune condition where the pancreas does not make insulin at all, so GLP-1's mechanism does not address the core problem. Talk to your endocrinologist about treatments designed for type 1.

What is the difference between Ozempic, Wegovy, and Rybelsus?

All three contain semaglutide but are marketed for different uses: Ozempic is for diabetes, Wegovy is for weight loss, and Rybelsus is an oral tablet (the others are injections). The active ingredient is the same, but dosing and approval status differ. Insurance coverage also varies by brand and indication.

Will I lose muscle along with fat on GLP-1?

Some muscle loss occurs during any significant weight loss, including on GLP-1 medications. Resistance training and eating enough protein can minimize this. If you are concerned about muscle loss, discuss a training plan with a fitness professional before starting the medication.

How long do I need to take a GLP-1 medication?

There is no set duration. Some people take it for a few months, others for years. Your doctor can help you decide based on your goals, side effects, and how well it is working. Stopping is a decision you and your doctor make together, not something the medication requires.